Impact of age and specific comorbidity index for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes benefiting from allogeneic stem cell transplants

首页> 外文期刊>Journal of international management >Impact of age and specific comorbidity index for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes benefiting from allogeneic stem cell transplants

【24h】

Impact of age and specific comorbidity index for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes benefiting from allogeneic stem cell transplants

机译：同种异体干细胞移植患者对同种异体造血干细胞移植同种异体造血干细胞移植的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of international management》 |2020年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 fre
中图分类管理学;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of age and specific comorbidity index for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes benefiting from allogeneic stem cell transplants [J] . Journal of international management . 2020,第2期

机译：同种异体干细胞移植患者对同种异体造血干细胞移植同种异体造血干细胞移植的影响
2. Impact of Busulfan Exposure on Transplant Outcomes for Patients with Advanced Myelodysplastic Syndrome Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation [J] . Proli Anthony J., Tamari Roni, Zheng Junting, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：丁硫磷暴露对接受CD34选择同种异体造血干细胞移植的晚期骨髓增生异常综合症患者移植结局的影响。
3. Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation [J] . Itonaga Hidehiro, Ishiyama Ken, Aoki Kazunari, Bone marrow transplantation . 2019,第9期

机译：同种异体造血干细胞移植治疗骨髓增生综合征患者患者结果的临床影响
4. Allogeneic hematopoietic stem cell transplantation from the nuclear age to the 21st century: lessons learned from dogs [C] . Rainer Storb Annual Veterinary Medical Forum . 2000

机译：异种造血干细胞移植到21世纪：从狗中吸取的经验教训
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case–control study [O] . Elias Jabbour, Michael S. Mathisen, Guillermo Garcia-Manero, -1

机译：异基因造血干细胞移植与骨髓增生异常综合征去甲基化药物：回顾性病例对照研究
7. Impact of Treatment Prior to Allogeneic Transplantation of Hematopoietic Stem Cells in Patients with Myelodysplastic Syndrome: Results of the Latin American Bone Marrow Transplant Registry [O] . Fernando Barroso Duarte, Anna Thawanny Gadelha Moura, Vaneuza Araújo Moreira Funke, 2020

机译：在骨髓增生术综合征患者中对造血干细胞同种异体移植治疗的影响：拉丁美洲骨髓移植登记处的结果

Impact of age and specific comorbidity index for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes benefiting from allogeneic stem cell transplants

著录项

相似文献

相关主题

期刊订阅